ProMed Pharma and DSM Biomedical recently announced a business development partnership focused on polymeric drug delivery. The collaboration combines ProMed’s micromolding and extrusion capabilities with DSM’s biomedical polyurethanes, polyurethaneureas, and bioerodible amino-acid-based polyesteramides. The goal is the development of novel … [Read more...] about ProMed Pharma, DSM partner to use polymers to deliver drugs